ST Pharm
ST Pharm
01
Who we are
02
Our record
03
Newsroom
04
Contact
En
Ko
ST Pharm
Science & Technology
Business Overview
사업영역
CDMO
위탁생산개발
Small Molecule
Oligonucleotide
mRNA
CRO
위탁임상서비스
AnaPath Research & Service
R&D
연구개발
Virtual R&D
Global R&D
About
ST PHARM
핵심인력
연혁
Global 인증
자회사
CI
Public
PR (Public Relations)
News room
All
Media Focus
ST PHARM News
IR (Investor Relations)
Stock Information
IR Library
Disclosure Information
IR Materials
Notice
Careers
ESG
Overview
Environmental
Social
Governance
Sitemap
Contact
Linkedin
Public
Media Focus
PR (Public Relations)
News room
All
Media Focus
ST PHARM News
IR (Investor Relations)
Stock Information
IR Library
Disclosure Information
IR Materials
Notice
Media Focus
Jan 16, 2023
에스티팜, 공급 경쟁 우려보다 성장성 주목
- 신한금융투자, 경쟁에 대한 우려보다 성장성을 지켜봐야, 목표주가 10만원, 투자의견 매수 유지
List